Press Releases
Combatting future viral threats with vaccine advances
In recent years, the pharmaceutical industry has seen a reduced timeline in vaccine development while advanced technologies have accelerated the development of new modalities. In this PharmTech article, Eonyoung Park, a lead scientist in our mRNA-based research team at Samsung Biologics, shares her insights on combatting future viral threats with vaccine advances.
Read more
In recent years, the pharmaceutical industry has seen a reduced timeline in vaccine development while advanced technologies have accelerated the development of new modalities. In this PharmTech article, Eonyoung Park, a lead scientist in our mRNA-based research team at Samsung Biologics, shares her insights on combatting future viral threats with vaccine advances.
Read more